Business Description
Kenvue Inc
NAICS : 811490
SIC : 2842
ISIN : US49177J1025
Total Employee Number:
22,000Compare
Compare
Traded in other countries / regions
KVUE.USA1KVUE.ItalyJ4D.GermanyKVUE.Mexico IPO Date
2023-05-03Description
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | 2.75 | |||||
Interest Coverage | 6.84 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.21 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.2 | |||||
3-Year EBITDA Growth Rate | -3.7 | |||||
3-Year EPS without NRI Growth Rate | -1.1 | |||||
3-Year FCF Growth Rate | -7.7 | |||||
3-Year Book Growth Rate | -19 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.76 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.05 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.87 | |||||
9-Day RSI | 43.91 | |||||
14-Day RSI | 50.41 | |||||
3-1 Month Momentum % | 6.48 | |||||
6-1 Month Momentum % | 6.52 | |||||
12-1 Month Momentum % | -16.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.98 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 98.5 | |||||
Days Sales Outstanding | 57.01 | |||||
Days Payable | 141.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.34 | |||||
Dividend Payout Ratio | 0.71 | |||||
Forward Dividend Yield % | 4.35 | |||||
5-Year Yield-on-Cost % | 4.22 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 4.56 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.37 | |||||
Operating Margin % | 19.19 | |||||
Net Margin % | 10.61 | |||||
EBITDA Margin % | 20.97 | |||||
FCF Margin % | 11.92 | |||||
OCF Margin % | 14.77 | |||||
ROE % | 15.36 | |||||
ROA % | 6.03 | |||||
ROIC % | 9.28 | |||||
3-Year ROIIC % | -14.27 | |||||
ROC (Joel Greenblatt) % | 123.7 | |||||
ROCE % | 12.71 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.07 | |||||
Forward PE Ratio | 16.33 | |||||
PE Ratio without NRI | 16.17 | |||||
PS Ratio | 2.36 | |||||
PB Ratio | 3.4 | |||||
Price-to-Free-Cash-Flow | 19.81 | |||||
Price-to-Operating-Cash-Flow | 15.98 | |||||
EV-to-EBIT | 16.56 | |||||
EV-to-Forward-EBIT | 14.76 | |||||
EV-to-EBITDA | 13.65 | |||||
EV-to-Forward-EBITDA | 14.21 | |||||
EV-to-Revenue | 2.86 | |||||
EV-to-Forward-Revenue | 2.81 | |||||
EV-to-FCF | 24 | |||||
Price-to-GF-Value | 0.92 | |||||
Earnings Yield (Greenblatt) % | 6.04 | |||||
FCF Yield % | 5.06 |
Kenvue Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kenvue Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 115 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 114 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | In 24 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 23 days | ||
| General meeting for 2026 | 2026-05-21 09:00 | 14.86 (+0.88%) | ||
| USD 0.207500 Cash Dividend | 2026-05-13 | 14.82 (+2.67%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 14.99 (+1.59%) | ||
| Annual report for 2025 | 2026-02-20 | 15.82 (-0.25%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-17 | 15.61 (+0.27%) | ||
| USD 0.207500 Cash Dividend | 2026-02-11 | 15.36 (+1.67%) |
Show
Entries
Press Release
Articles on Kenvue Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers